-

Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes

Groups welcome reversal of Gilead’s price gouging decision that would have resulted in fewer people with HIV getting access to lifesaving treatment.

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) was victorious killing Gilead Sciences’ plan to institute high-single digit price hikes for several of its HIV medications, hikes that would have gutted the nation’s AIDS Drug Assistance Programs (ADAPs).

AHF sent a letter signed by over 100 organizations to Gilead CEO Daniel O’Day demanding the company hold off on the price hikes. The following day, Gilead announced that it agreed not to boost prices on its key HIV medications, according to STAT News.

Share

Last week, following months of negotiations between Gilead and state ADAP programs, AHF sent a letter signed by over 100 organizations nationwide to Gilead CEO Daniel O’Day demanding the company hold off on the proposed hikes. The following day, Gilead announced that it had agreed not to boost prices on its key HIV medications, according to STAT News.

ADAPs, a national network of state AIDS drug programs, are a lifeline for low-income patients. The price hike would have meant ADAPs would have furnished fewer prescriptions to those most in need.

Unfortunately, Gilead’s initial decision to make life-saving therapeutics more expensive for ADAPs was not a one-off but follows a pattern under the leadership of Gilead’s CEO, Daniel O’Day.

O’Day ruthlessly seeks to boost profits by restricting access to Gilead’s HIV medicines. From patent manipulation to curtailing patient assistance programs, O’Day has proven that drug giants do not need to innovate to make money. Under his tenure, Gilead has put up multiple roadblocks to make it harder for medically underserved Americans to attain their medications. O’Day has had one goal – maximizing profits of the older drugs in Gilead’s portfolio instead of investing in the breakthrough HIV therapeutics of the future.

AIDS Healthcare Foundation (AHF), the world’s largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.6 million individuals across 49 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. To learn more about AHF, visit us online at AIDShealth.org, find us on Facebook, and follow us on Instagram, Twitter, and TikTok.

Contacts

MEDIA CONTACTS:
John Hassell,
AHF National Director of Advocacy
1.202.774.4854 mobile. john.hassell@ahf.org

Ged Kenslea, Sr. Director, Communications, AHF
1.323.791.5526 mobile ged.kenslea@ahf.org

AIDS Healthcare Foundation


Release Summary
Victory! AHF, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes
Release Versions

Contacts

MEDIA CONTACTS:
John Hassell,
AHF National Director of Advocacy
1.202.774.4854 mobile. john.hassell@ahf.org

Ged Kenslea, Sr. Director, Communications, AHF
1.323.791.5526 mobile ged.kenslea@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

Club de Madrid and AHF Global Public Health Institute Co-Host High-Level Roundtable on Rebalancing Global Health

NEW YORK--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) Global Public Health Institute, Club de Madrid and partners will join the Governments of Spain and Zambia in co-hosting a high-level roundtable, “Rebalancing Global Health: Regional Platforms, Equity, and Fiscal Space for Public Health Security,” on Thursday, Sept. 24, 2026, from 8:30 to 10:30 a.m. at the University Club in New York City and online via Zoom. The event will occur on the margins of the 81st United Nations General Ass...

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

MEXICO CITY--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest HIV care provider, welcomes a new agreement between Gilead Sciences and the Pan American Health Organization (PAHO) that could expand access to lenacapavir for HIV prevention in 14 countries across Latin America. The agreement represents a positive step toward expanding access in the region and a victory for civil society. AHF was among the first organizations to mobilize around concerns that the initial Gilead-...

AHF to Commemorate 40 Years of Global Impact During Annual World AIDS Day Concert Celebration

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), the world’s largest, non-profit public health organization providing direct HIV/AIDS services to over 3.3 million clients across the globe, will celebrate 40 years of impact during its annual World AIDS Day concert commemoration. The event, which is free and open to the public, is scheduled for the evening of Monday, November 30, 2026, at the Kia Forum in Inglewood, California. RSVP to AHFWAD.org for tickets. Commemorated annually...
Back to Newsroom